6533b851fe1ef96bd12a8f04
RESEARCH PRODUCT
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
Giuseppe CabibboAntonio CraxìCalogero Cammàsubject
OncologyRiskmedicine.medical_specialtyCarcinoma HepatocellularHepatologybusiness.industryEarly RecurrenceLiver NeoplasmsMEDLINEhepatocellular carcinomamedicine.diseaseAntiviral Agents03 medical and health sciences0302 clinical medicineNeoplasm RecurrenceNothing030220 oncology & carcinogenesisInternal medicineCarcinomamedicineHumans030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusinessdescription
.
year | journal | country | edition | language |
---|---|---|---|---|
2016-04-25 |